Evidence map›Paper›PMID 9933430›Full record

ArticleClinical and experimental immunology1999

Circulating cytokine balance and activation markers of leucocytes in Q fever.

C Capo, N Amirayan, E Ghigo, D Raoult, J Mege

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Recent Advances on the Innate Immune Response toFrontiers in cellular and infection microbiology · 2021
    Review
  8. Article
  9. Article
  10. Interaction ofFrontiers in cellular and infection microbiology · 2017
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

C CapoUnité des Rickettsies, Université de la Méditerranée, CNRS UPRES A 6020, Faculté de Médecine, Marseille, France.
N Amirayan
E Ghigo
D Raoult
J Mege
Institut de Neurobiologie de la Méditerranée · FRHôpital de la Conception · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As Q fever is associated with an inflammatory syndrome, we determined circulating levels of inflammatory cytokines, cytokine antagonists, and activation markers of leucocytes in patients with acute Q fever and Q fever endocarditis. Tumour necrosis factor (TNF) and IL-6, but not IL-1beta, were markedly increased compared with controls. Cytokine antagonists and activation markers of leucocytes were profoundly different in acute and chronic Q fever. IL-1 receptor antagonist and TNF receptor type II were significantly increased in patients with acute Q fever, suggesting a shift of cytokine balance towards cytokine antagonists. The activation marker of B cells, sCD23, was significantly increased in Q fever endocarditis compared with controls and patients with acute Q fever. In a 2-year follow-up study of patients with Q fever endocarditis, sCD23 and specific IgG levels slowly decreased in patients whose symptoms resolved, but remained high in those who required prolonged treatment.

Indexed as

AdultAgedBiomarkersCytokinesEndocarditis, BacterialFemaleHumansInterleukin 1 Receptor Antagonist ProteinLeukocytesLipopolysaccharide ReceptorsMaleMiddle AgedNeopterinQ FeverReceptors, IgESialoglycoproteinsBiomarkersCytokinesIL1RN protein, humanInterleukin 1 Receptor Antagonist ProteinLipopolysaccharide ReceptorsNeopterinReceptors, IgESialoglycoproteins

Identifiers

PMID9933430
PMCPMC1905180
OpenAlexW2041570680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.